跳至主要内容
临床试验/ACTRN12623000685617
ACTRN12623000685617尚未招募Unknown

RESPONSIBLE PRE-OPERATIVE OPIOID USE FOR HIP AND KNEE ARTHROPLASTY II (OPIOIDHALT II) STUDY: Opioid tapering in patients prior to hip or knee arthroplasty.

The Commonwealth of Australia represented by the Department of Health and Aged Care (Funding Agreement managed by The Department of Industry, Science and Resources)0 个研究点目标入组 314 人开始时间: 2023年6月26日最近更新:
适应症

试验速览

阶段
Unknown
状态
尚未招募
发起方
入组人数
314

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional
分配方式
Randomised controlled trial
主要目的
Educational / counselling / training
盲法
Blinded (masking used)

入排标准

年龄范围
18 Years 至 105 Years(—)
性别
All

入选标准

  • Randomized Study:
  • Aged 18 years or older, undergoing elective THA or TKA for osteoarthritis, speaks and reads English, uses prescription opioid analgesics daily, and has access to the internet or telephone.
  • Criteria for GP review: Psychological distress and suicidality will be screened using the 6-item Kessler Psychological Distress Scale (K6) and the 3-item Patient Safety Screener (PSS). Patients with: (i) a K6 score of 19 or greater AND PSS criteria 1 (feeling down, depressed, or hopeless over past two weeks); OR (ii) PSS criteria 2 (thoughts of killing yourself over past two weeks); OR (iii) PSS criteria 3 (ever attempted to kill yourself) AND report suicidality in the past 6 months will be referred to their GP to confirm whether participation in the trial is appropriate.

排除标准

  • Patients undergoing planned repeat surgeries (same procedure within 6 months), using opioids for cancer, palliative care, or substance use disorder, previously or already undergoing an opioid tapering program or active medication review, and major cognitive impairment.

研究者

发起方
The Commonwealth of Australia represented by the Department of Health and Aged Care (Funding Agreement managed by The Department of Industry, Science and Resources)

相似试验

Responsible Opioid Use for Hip and Knee Arthroplasty... | 临床试验